Get the Stockscreener App
17.40
2.79%
-0.50
Adma Biologics Inc stock is traded at $17.40, with a volume of 6.33M.
It is down -2.79% in the last 24 hours and down -18.58% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$17.90
Open:
$17.16
24h Volume:
6.33M
Relative Volume:
1.46
Market Cap:
$4.11B
Revenue:
$382.81M
Net Income/Loss:
$68.13M
P/E Ratio:
-87.00
EPS:
-0.2
Net Cash Flow:
$78.82M
1W Performance:
-6.40%
1M Performance:
-18.58%
6M Performance:
+62.46%
1Y Performance:
+325.43%
1-Day Range:
$17.08
$17.96
1-Week Range:
$17.08
$19.19
52-Week Range:
$4.07
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
17.40 | 4.11B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
Tidal Investments LLC Lowers Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Shares Gap DownHere's Why - MarketBeat
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility - The Manila Times
ADMA Biologics, Inc. Announces Partial Paydown of Senior Term Loan Credit Facility - Marketscreener.com
The Zacks Analyst Blog Highlights Sarepta Therapeutics, ADMA Biologics, Exelixis and Alnylam - Yahoo Finance
Teachers Retirement System of The State of Kentucky Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Geode Capital Management LLC Boosts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Wellington Management Group LLP Has $2.39 Million Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics shares target lifted on strong product momentum By Investing.com - Investing.com Canada
Barclays PLC Acquires 347,692 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Lord Abbett & CO. LLC Acquires New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Down 9.3% in November - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript - MSN
ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into ADMA Biologics Inc and Encourages Investors to Contact the Firm - The Eastern Progress Online
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year? - Yahoo Finance
Neo Ivy Capital Management Acquires Shares of 48,584 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by State Street Corp - MarketBeat
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm - The Eastern Progress Online
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip? - Yahoo Finance
Fmr LLC Purchases 68,881 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
(ADMA) Technical Data - Stock Traders Daily
Zacks Investment Management Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Virtus Investment Advisers Inc. Sells 79,371 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Two Sigma Advisers LP - MarketBeat
Looking Into ADMA Biologics's Recent Short Interest - Benzinga
Cerity Partners LLC Raises Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Walleye Capital LLC Grows Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Verition Fund Management LLC Buys 134,739 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Can Adma Biologics (ADMA) Climb 25.5% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance
Miura Global Management LLC Reduces Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - Zacks Investment Research
ADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIV - Seeking Alpha
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Down 6.3% in November - MarketBeat
PDT Partners LLC Invests $1.28 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Charles Schwab Investment Management Inc. Purchases 249,412 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
BNP Paribas Financial Markets Buys 85,250 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 3.4%Time to Sell? - MarketBeat
Citigroup Inc. Boosts Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
FORA Capital LLC Buys Shares of 41,547 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Public Sector Pension Investment Board Takes $9.89 Million Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Has $13.17 Million Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Bank of Montreal Can Has $40.44 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - MSN
(ADMA) Proactive Strategies - Stock Traders Daily
Intech Investment Management LLC Buys Shares of 62,120 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Mutual of America Capital Management LLC Purchases New Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Subdued Growth No Barrier To ADMA Biologics, Inc. (NASDAQ:ADMA) With Shares Advancing 36% - Simply Wall St
ADMA Biologics, Inc. Announces Executive Changes - Marketscreener.com
Advantage Alpha Capital Partners LP Has $1.75 Million Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):